2-Day Virtual Seminar FDA Audit, Quality Assurance Practices, Responsibilities and Expectations

Kenneth Christie
May 20 - May 21 , 2021
Starting at


Premier price: $1614 (save 5%)

Single registration

May 20 - May 21 , 2021
Buy Now

It is no surprise to anyone who reviews regulatory citations to notice the number of deficiencies cited that are associated with quality systems. Today, the basis for all FDA audits both within the US and internationally is based on the quality systems approach and the six systems that comprise it. Whether the audit is a full or partial audit, the quality system within a company will always be inspected and this seminar will help review what are the expectations and the common areas to be familiar with. As a basis for regulatory audits, the quality system, its procedures and their implementation are reviewed to help verify the level of effectiveness in assuring consistent control and quality of materials, components and final product.

This training will examine the differences between Quality Assurance and Quality Control and the responsibilities of each. In addition, attendees will discuss what characteristics quality personnel should possess. The current expectations for an effective quality system program as defined in both the FDA and EU requirements and guidance documents will be reviewed. Topics to be covered will range from the development of a quality manual and procedures, the importance and scope of audits (internal, vendor, third party and regulatory) along with review of various case studies to help further illustrate points discussed.

The quality department within companies is responsible for nearly all activities to various degrees that have impact on the quality, safety or efficacy of the final product or material produced. It is also responsible for helping assure that contracted services, which is more common today than ever before, are also verified to meet the quality standards set both by the company and the regulatory requirements. The training will review special topics of interest to auditors such as CAPA programs and investigations that address deviations and out of specification (OOS) results. Attendees will be given ample opportunity to ask questions, discuss actual case studies and to learn about the vast scope of responsibility that the quality system regulations expect and the roles of their own positions..

Learning Objectives:

Upon completing this course participants should:

  • Understand the regulatory expectations of the quality unit and its role in the Quality System Requirements (QSR)
  • Review the Quality areas that are the point of focus during regulatory, corporate or third party audits.
  • Review typical checklist that can be used as a template for the performance of audits
  • Evaluate the importance of training, its documentation, and common concerns being raised over "operator error"
  • Review the importance and regulatory guidance offered for the investigation of deviations/out-of-specification results.
  • Review the current focus on data integrity issues and the current guidance document regarding it
  • Review the top 10 most commonly cited drug GMP deficiencies for 2015-2016
  • Understand the weaknesses of each person's current quality system and discuss possible recommended corrective actions

Who will Benefit:

This course is designed for people within the quality unit, those impacted by quality requirements, third party suppliers who are evaluated against quality issues and their adherence to them, along corporate management who is required to provide the time and resources to correct quality issues identified. This includes individuals that have Quality Management Systems responsibilities for making general improvements in their organization's performance. Following personnel will benefit from the course:

  • Senior quality managers
  • Quality professionals
  • Regulatory professionals
  • Compliance professionals
  • Production supervisors
  • Manufacturing engineers
  • Production engineers
  • Design engineers
  • Process owners
  • Quality engineers
  • Quality auditors
  • Document control specialists
DAY 01(9:00 AM TO 5:00 PM EDT)
  • Review of Regulatory requirements for the quality organization within companies. Will examine current FDA (21 CFR parts 210-211 and 820), EU and Health Canada requirements.
  • Discuss the importance of audits as a means of assuring compliance and the ability of the Quality System to meet its responsibilities.
  • Review importance of internal and vendor audits and provide a checklist of items to be covered and reviewed. Discuss expectations for applicable procedures covering these topics.
  • Discuss audit techniques that will help assure successful results when preparing for audits.
  • Review current industry guidelines for the investigation of "Out-of-Specification" (OOS) laboratory results.
  • Review current FDA Guidance document dealing with data integrity and issues that companies should implement.
DAY 02(9:00 AM TO 5:00 PM EDT)
  • Discuss areas of concern and focus during laboratory audits.
  • Review importance and requirements for personnel training.
  • Discuss current concerns by FDA and EU auditors regarding "operator error" when listed as the "root cause" for deviation investigations.
  • Review importance and requirements for vendor evaluations and quality agreements. What to look for, what to be included, etc. Discuss actual case studies as to actions taken by vendors and their potential impact on component, service or product quality.
  • Discuss importance of CAPA process and change control programs that help maintain compliance and prevent occurrences of deviations.
  • Review the 10 most common drug GMP deficiencies cited by the FDA inspectors during 2015-2016. Learn what quality systems are found most deficient.

Each days training will include actual case studies to highlight topics covered, review of applicable forms that can be used as templates for change control, or audit checklists, etc. Attendees will have ample opportunity to ask questions regarding current industry practices or their own company practices.

Seminar (Price/Register)
May 20 - May 21 , 2021

Single registration

Group-Max. 10 Attendees

Seminar Fee Includes:
AM-PM Tea/Coffee
Seminar Material
Attendance Certificate
$100 Gift Cert for next seminar

Other Registration Option
  1. Download the Order Form
  2. Fill this form with attendee details & payment details
  3. Fax your PO to 1-888-883-7697 or,
  4. Email it to cs@compliance.world

Payment Mode

By Check -

Pay your check issued from the payee to "Redstone Learning Inc." (Our Parent Company) and mail the check to –
Compliance.world (Redstone Learning Inc.)
1180 Avenue of the Americas,
8th Floor, New York,
NY 10036

  Media Partners

If you wish to partner with us for this event

please contact us: partner or
call us: 1-866-978-0800

Media Partner Benefits

  • Logo and company data on the event website.
  • Logo on the conference material distributed during the conference.
  • Media Partner’s brochure distributed along with conference material.
  • Logo on all the mailings before and after the event.
  • 10% discount to media partner's subscribers.

Media Partner to do

  • Banner (min 728x90 or 468x60) on the Media Partner website.
  • Insertion of the event in the event calendar, both printed and/or online.
  • Announcement article of the conference on the Magazine and/or Website.
  • Dedicated email blast to all subscribers of Media Partner.
  • Article on the Magazine and/or Website after the conference.


If you wish to partner with us for this event

please contact us: sponsor@compliance.world or
call us: 1-866-978-0800
Speaker: Kenneth Christie,

Kenneth Christie has over 30 years of sterile manufacturing and regulatory GMP consulting experience in the areas of Quality Assurance and Validation Management in the pharmaceutical and biotechnology industries. Mr. Christie is currently the Chief Operating Officer for VTS Consultants, Inc. located in Amherst, MA. Specifically, his responsibilities include quality system auditing, GMP training, and serving as a subject matter expert for aseptic manufacturing processes, equipment and utilities, medical devices, and solid dosage processes on a global basis. Mr. Christie also performs vendor audits, site pre-approval inspections and assists clients with addressing and correcting regulatory observations. Mr. Christie was the Validation Manager at Parke-Davis' Sterile Products Facility where he was involved in the review and approval of all facilities, equipment, and system commissioning/qualification activities. He had routine interaction with the FDA and European inspectors (EMEA), corporate management and third party contract-manufacturing representatives to defend validation practices and to assure regulatory compliance for the manufacture of aseptically produced products. Mr. Christie is a speaker and trainer for several professional organizations in the US, Canada, Europe, and Asia and is a published author of several articles dealing with the challenges of aseptic processing. Additionally, Mr. Christie served as a member of the ISPE’s Professional Certification (PCC) Commission as an Examination Development Committee (EDC) member. He possesses a BS degree in Biology from Shippensburg State University (PA) and an Executive MBA degree from Michigan State.

Get in touch

(315) 632-0735,
(315) 750-4379